| Pediatric rheumatologists | Pediatric nephrologists | p-value |
---|---|---|---|
n = 56 (100%) | n = 31 (100%) | ||
CYC route | Â | Â | Â |
 Oral | N/A | 2 (6%) |  |
 Intravenous | 56 (100%) | 29 (94%) | 0.253 |
CYC dose | Â | Â | Â |
 500 mg/m² BSA | 34 (61%) | 22 (71%) | 0.338 |
 750 mg/m² BSA | N/A | 2 (6%) |  |
 1000 mg/m² BSA | 22 (39%) | 7 (23%) | 0.113 |
Max CYC dose | Â | Â | Â |
 500 mg | 3 (5%) | 3 (10%) | 0.446 |
 750 mg | 9 (16%) | 3 (10%) | 0.442 |
 1000 mg | 42 (75%) | 22 (71%) | 0.682 |
 1500 mg | 2 (4%) | 2 (6%) | 0.539 |
 2000 mg | N/A | 1 (3%) |  |
Number of CYC pulses in induction therapy? | Â | Â | Â |
 3 | 2 (4%) | 5 (16%) | 0.039 |
 6 | 54 (96%) | 26 (84%) |  |
The time interval between CYC pulses | Â | Â | Â |
 2 weeks | 9 (16%) | 5 (16%) | 0.994 |
 1 month | 47 (84%) | 26 (84%) |  |
Do you apply uromitexan together with CYC? | Â | Â | Â |
 Yes | 55 (98%) | 30 (97%) | 0.667 |